In this study, we used cancer stem cell surface marker CD44+/CD24-/low, a first described marker for BCSCs [32, 33], and embryonic stem cell markers Oct3/4 [34], Sox II [35] and Nanog [36] to determine the putative cancer stem cells. Here, NANOG is linked to cancer.